Analysis of clinical studys on acupuncture and moxibustion therapy for urticaria: an evidence map.
10.13703/j.0255-2930.20240906-0002
- Author:
Meng LI
1
;
Xiaoyi HU
1
;
Zhen LUO
1
;
Jie MA
2
;
Tianyu MING
1
;
Weijuan GANG
1
;
Shihao DU
1
;
Xianghong JING
1
Author Information
1. Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences, Beijing 100700, China.
2. Department of Dermatology, China-Japan Friendship Hospital.
- Publication Type:Journal Article
- Keywords:
acupuncture and moxibustion therapy;
evidence map;
randomized controlled trials (RCT);
systematic review;
urticaria
- MeSH:
Humans;
Moxibustion;
Acupuncture Therapy;
Urticaria/therapy*;
Acupuncture Points;
Randomized Controlled Trials as Topic;
Adolescent;
Adult;
Young Adult
- From:
Chinese Acupuncture & Moxibustion
2025;45(10):1519-1526
- CountryChina
- Language:Chinese
-
Abstract:
Through collecting the existing clinical evidences on acupuncture and moxibustion for urticaria, the distribution of evidence in this field was mapped. A systematic search of Chinese and English literature was conducted in CNKI, Wanfang, VIP, SinoMed, PubMed, EMbase, and Cochrane Library for treatment of urticaria with acupuncture and moxibustion, published up to December 31, 2023 since inception of each database. The research status in this field was summarized using an evidence mapping approach, and methodological quality was assessed. A total of 323 randomized controlled trials (RCTs) and 22 systematic reviews were included. The number of studies on acupuncture and moxibustion for urticaria has been increasing, with a significant rise in recent years. In most RCTs, the study scale was small, and the subjects focused on chronic spontaneous urticaria in adolescents and middle-aged adults, aged 14 to 60 years. Regarding the intervention measures, the single therapy of acupuncture and moxibustion was predominant such as acupoint injection, acupoint embedding thread, and filiform needling. In acupuncture with filiform needles, the commonly used acupoints were Quchi (LI11), Xuehai (SP10), Sanyinjiao (SP6), Zusanli (ST36) and Hegu (LI4). The main outcome measures referred to effectiveness rate, score of disease severity, recurrence rate, laboratory indexes, and score of quality of life; and the short-term effect was evaluated specifically. The overall methodological quality of the included studies was relatively low. It is suggested that the future research should focus on large-scale, multi-center, high-quality clinical trials, optimize the protocols for acupuncture and moxibustion intervention, standardize the outcomes, and draw the attention to the evaluation of long-term efficacy, so as to provide clinical evidences of high certainty for urticaria treated with acupuncture and moxibustion.
